Viral load and clinicopathological features of chronic hepatitis C (1b) in a homogeneous patient population. NLM AIDSLINE Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Viral load and clinicopathological features of chronic hepatitis C (1b) in a homogeneous patient population.

Hepatology. 1999 Mar;29(3):904-7. Unique Identifier : AIDSLINE MED/99162385
Fanning L; Kenny E; Sheehan M; Cannon B; Whelton M; O'Connell J; Collins JK; Shanahan F; Department of Medicine, National University of Ireland, Cork,; University College Cork, Ireland. L.FANNING@UCCE.IE


Abstract: Monitoring the progression of hepatitis C virus (HCV) includes clinical, biochemical, and histological parameters. Quantitation of viral load by reverse-transcription polymerase chain reaction (RT-PCR) may offer a more reliable marker of disease status. Conflicting reports on viral titers may reflect heterogeneity of patient population, mode of infection, and viral type/subtype. The aim of this study was to correlate quantitative serum viral load with alanine transaminase (ALT) and histological status in a homogenous population. The study population consisted of 77 Rhesus-negative women with chronic hepatitis C type 1b. Homogenous features of this study population included: same defined source of infection (contaminated anti-D immunoglobulin); same duration of disease (17 years at the time of study); same viral type/subtype; same ethnic origin; all healthy child-bearing females at the time of infection; and an absence of competing risk factors for infectious and other liver diseases. None of the patients had received antiviral treatment at the time of study. Liver biopsy was performed on all patients. All biopsies were scored by a single histopathologist who was blinded to the clinical and viral status of each patient. A weak, but statistically significant, correlation (rs =.26; P <.05) between serum viral load and the degree of inflammation (mean value: 3.87 +/- 2.17 [SD]) was found. There was no significant correlation between serum viral load and the degree of fibrosis (mean value: 0.84 +/- 0.8 [SD]; P =.06). There was no significant correlation between serum viral load and ALT, although there was a correlation between ALT and the degree of inflammation (rs =.241; P =.035).
Keywords: JOURNAL ARTICLE Adult Alanine Transaminase/BLOOD Female Hepatitis C-Like Viruses/GENETICS Hepatitis C, Chronic/BLOOD/COMPLICATIONS/*PATHOLOGY/*VIROLOGY Human Liver/PATHOLOGY Liver Cirrhosis/ETIOLOGY/PATHOLOGY Middle Age RNA, Viral/ANALYSIS Support, Non-U.S. Gov't *Viral LoadKWDjournalarticleadultalaninetransaminase/bloodfemalehepatitisc-likeviruses/geneticshepatitisc,chronic/blood/complications/KWDpathology/KWDvirologyhumanliver/pathologylivercirrhosis/etiology/pathologymiddleagerna,viral/analysissupport,non-uKWDsKWDgov'tKWDviralload
990630
A9960930

Copyright © 1999 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .